Sarepta Therapeutics, Inc. (SRPT) Social Stream



Sarepta Therapeutics, Inc. (SRPT): $124.28

0.68 (+0.55%)

POWR Rating

Component Grades

Momentum

B

Stability

D

Sentiment

Quality

C

Add SRPT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#87 of 378

in industry

SAREPTA THERAPEUTICS INC (SRPT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SRPT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 16 $160 $90 $127.25 $128.86 -1.25%
2021-12-26 16 $160 $90 $127.076 $128.86 -1.38%
2022-01-05 16 $160 $90 $126.538 $128.86 -1.8%
2022-01-11 13 $160 $90 $128.083 $128.86 -0.6%
2022-01-19 14 $160 $90 $128.083 $128.86 -0.6%
2022-01-26 14 $160 $92 $126.833 $128.86 -1.57%
2022-02-09 14 $160 $71 $125.083 $128.86 -2.93%
2022-03-04 13 $150 $71 $121.909 $128.86 -5.39%
2022-03-07 13 $150 $80 $122.727 $128.86 -4.76%
2022-03-16 13 $150 $80 $123 $128.86 -4.55%
2022-04-04 13 $150 $80 $124.3 $128.86 -3.54%
2022-04-12 13 $150 $77 $124 $128.86 -3.77%
2022-04-20 13 $150 $77 $124.2 $128.86 -3.62%
2022-05-09 13 $150 $77 $124.1 $128.86 -3.69%
2022-05-13 13 $150 $77 $124.6 $128.86 -3.31%
2022-05-18 13 $150 $74 $124.3 $128.86 -3.54%
2022-05-24 14 $155 $74 $127.09 $128.86 -1.37%
2022-06-22 13 $155 $74 $127.09 $128.86 -1.37%
2022-07-25 13 $155 $80 $126.272 $128.86 -2.01%
2022-07-29 13 $162 $80 $127.363 $128.86 -1.16%
2022-08-03 13 $162 $80 $127.583 $128.86 -0.99%
2022-08-04 13 $162 $100 $132.076 $128.86 2.5%
2022-08-09 13 $182 $100 $133.769 $128.86 3.81%
2022-08-13 13 $182 $100 $134.923 $128.86 4.71%
2022-09-06 13 $182 $100 $136.461 $128.86 5.9%
2022-09-07 13 $182 $100 $137.461 $128.86 6.67%
2022-09-14 13 $182 $114 $140.153 $128.86 8.76%
2022-10-03 12 $182 $114 $140.153 $128.86 8.76%
2022-10-12 12 $182 $114 $141.916 $128.86 10.13%
2022-10-20 12 $182 $114 $143.5 $128.86 11.36%
2022-10-21 12 $182 $114 $144 $128.86 11.75%
2022-11-25 12 $190 $114 $146.153 $128.86 13.42%
2022-12-02 12 $190 $114 $146.846 $128.86 13.96%
2022-12-19 13 $190 $114 $147.642 $128.86 14.58%
2022-12-22 14 $190 $114 $148.466 $128.86 15.21%
2022-12-29 14 $190 $114 $150.066 $128.86 16.46%
2023-01-04 15 $190 $114 $151.533 $128.86 17.6%
2023-01-10 15 $190 $114 $151.666 $128.86 17.7%
2023-01-16 15 $190 $122 $152.4 $128.86 18.27%
2023-02-27 15 $190 $122 $153.4 $128.86 19.04%
2023-03-01 16 $190 $122 $154.933 $128.86 20.23%
2023-03-02 16 $226 $122 $169 $128.86 31.15%
2023-03-09 16 $226 $122 $170.533 $128.86 32.34%
2023-03-17 16 $226 $122 $171.666 $128.86 33.22%
2023-03-21 16 $226 $122 $171.333 $128.86 32.96%
2023-03-22 16 $226 $122 $174.666 $128.86 35.55%
2023-04-05 18 $226 $122 $174.058 $128.86 35.08%
2023-04-24 18 $226 $122 $173.823 $128.86 34.89%
2023-05-03 19 $226 $122 $174.444 $128.86 35.37%
2023-05-04 19 $206 $122 $170.222 $128.86 32.1%
2023-05-10 19 $206 $122 $171.5 $128.86 33.09%
2023-05-15 19 $206 $122 $173 $128.86 34.25%
2023-05-24 19 $218 $122 $177 $128.86 37.36%
2023-05-25 19 $218 $122 $176.722 $128.86 37.14%

The Trend in the Analyst Price Target


Over the past 25 months, SRPT's average price target has gone up $42.37.

Over the past 48 weeks, SRPT's average upside potential has been 27.31%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-09 13 182 100 133.769 109.10 22.61%
2022-08-13 13 182 100 134.923 109.00 23.78%
2022-11-03 12 190 114 146.153 105.01 39.18%
2023-01-16 15 190 122 152.400 126.70 20.28%
2023-01-31 15 190 122 153.400 124.97 22.75%

SRPT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.32 15 2 2 0 0 19

The Trend in the Broker Recommendations


Over the past 36 months, SRPT's average broker recommendation rating worsened by 0.15.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • SRPT has a higher average analyst price target than 5503.88% of Pharmaceutical Products stocks.
  • SAREPTA THERAPEUTICS INC's number of analysts covering the stock is higher than 5371.37% of Pharmaceutical Products stocks.
  • In terms of how SAREPTA THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 862.82% of that group.
  • SRPT has a lower variance in analysts' estimates than -3852.62% of stocks in the large market cap category.

In the Pharmaceutical Products industry, REGN, BMY, and LEGN are the three stocks most similar to SAREPTA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding SRPT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7756 seconds.